These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23162890)

  • 1. [Pharmacokinetics and administration of drugs in patients with hepatic failure].
    Yamada S; Suou T
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():348-52. PubMed ID: 23162890
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics and administration of drugs in patients with hepatic failure].
    Yamada S; Suou T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():53-7. PubMed ID: 18074517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjusting dosage of drugs in patients with kidney or liver failure].
    Krähenbühl S
    Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severity of liver inflammation is associated with enhanced hepatic Th1 cytokine in patients with HBV-related liver cirrhosis].
    Zhang P; Chen T; Gong Y; Shen LW; Gao T; Xue F; Xia Q; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):861-3. PubMed ID: 21138639
    [No Abstract]   [Full Text] [Related]  

  • 5. [Principles and practical guidelines for drug dosages in liver diseases. II].
    Saudek F
    Cas Lek Cesk; 1984 Aug; 123(33):1018-23. PubMed ID: 6498889
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic Changes in Liver Failure and Impact on Drug Therapy.
    Diep U; Chudow M; Sunjic KM
    AACN Adv Crit Care; 2017; 28(2):93-101. PubMed ID: 28592464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Individualization of drug therapy in renal or liver insufficiency].
    Martin-Facklam M
    Ther Umsch; 2000 Sep; 57(9):568-72. PubMed ID: 11036437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug dosing considerations for the critically ill patient with liver disease.
    Lin S; Smith BS
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):335-40. PubMed ID: 20691384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [6/12. Drugs and hepatic insufficiency].
    Lacroix V; Woronoff-Lemsi MC
    Soins; 2001 Sep; (658):53-4. PubMed ID: 12008470
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics in liver cirrhosis].
    Ackermann E
    Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin rhythms in patients with cirrhosis.
    Montagnese S; Middleton B; Mani AR; Skene DJ; Morgan MY
    Am J Gastroenterol; 2010 Jan; 105(1):220-2; author reply 222. PubMed ID: 20054310
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
    Dreux C; Passa P; Halter D
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):289-96. PubMed ID: 552592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of vitamin K in hepatic cirrhosis].
    Otero Fernández MA; Romero-Gómez M; Martínez Delgado C; González Suárez M
    Aten Primaria; 1999 Sep; 24(4):242-3. PubMed ID: 10547918
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histochemical research in chronic hepatitis and hepatic cirrhosis. I. Histochemistry of hepatic mucopolysaccharides].
    Mihai C; Bona C; Marinescu N; Dona D
    Med Interna (Bucur); 1967 Oct; 19(10):1235-48. PubMed ID: 4230218
    [No Abstract]   [Full Text] [Related]  

  • 15. [Total parenteral and enteral nutrition in hepatitis and hepatic failure].
    Arakawa Y; Moriyama M; Amaki S; Tanaka N
    Nihon Rinsho; 2001 May; 59 Suppl 5():586-96. PubMed ID: 11439605
    [No Abstract]   [Full Text] [Related]  

  • 16. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
    Kayacetin E; Köklü S; Temuçin T
    Dig Liver Dis; 2004 Jun; 36(6):419-22. PubMed ID: 15248383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of carbohydrate metabolism in diseases of the liver on the basis of intravenous glucose and fructose administration in patients with hepatitis and liver cirrhosis].
    Meythaler F
    Landarzt; 1964 Aug; 40(23):971-6. PubMed ID: 5827937
    [No Abstract]   [Full Text] [Related]  

  • 19. Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic hepatitis C.
    Imazeki F; Yokosuka O; Fukai K; Kawai S; Kanda T; Kojima H; Saisho H
    Liver Int; 2005 Aug; 25(4):772-8. PubMed ID: 15998428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood.
    Wolber EM; Ganschow R; Burdelski M; Jelkmann W
    Hepatology; 1999 Jun; 29(6):1739-42. PubMed ID: 10347116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.